Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session.
GRASSLEY CONFIRMS DELAY ON DRUG BILL WHILE ANOTHER COMMITTEE PLANS VOTES
Senate Finance Committee Chairman Chuck Grassley, R-Iowa, last week confirmed that his planned drug pricing legislation won’t be unveiled until after lawmakers return from a the Fourth of July recess.
But Senate Judiciary Committee Chairman Lindsey Graham, R-S.C., is pressing ahead with a vote this month on legislation that aims to thwart “anti-competitive use of patents” that prevent generic drug and biosimilar competition. The bill by Sens. John Cornyn, R-Texas, and Richard Blumenthal, D-Conn., would authorize the Federal Trade Commission to step in if “patent tickets” are being used to stifle generic competition. Continue Reading